New Key Statistics Module, Z-Score and F-Score
OTCPK:CSBTF Key Ratios
| Market Cap $ M | 659.87 |
| Enterprise Value $ M | 645.40 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 9.25 |
| Price/Sales | 10.61 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 59.00 |
| EPS (TTM) $ | -0.29 |
| Beneish M-Score | -2.04 |
| 10-y EBITDA Growth Rate % | 49.00 |
| 5-y EBITDA Growth Rate % | 21.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -69.84 |
| EV-to-EBITDA | -105.16 |
| PEG | -- |
| Shares Outstanding M | 36.91 |
| Net Margin (%) | -16.91 |
| Operating Margin % | -17.55 |
| Pre-tax Margin (%) | -14.03 |
| Quick Ratio | 2.17 |
| Current Ratio | 2.73 |
| ROA % (ttm) | -11.74 |
| ROE % (ttm) | -14.74 |
| ROIC % (ttm) | -18.69 |
| Dividend Yield % | -- |
| Altman Z-Score | 21.90 |
CSBTF Number of Guru Trades
CSBTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CSBTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CSBTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kuros Biosciences Ltd Insider Transactions
No Available Data
News about OTCPK:CSBTF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers